Inhibition of 6-hydroxydopamine-induced oxidative damage by 4,5-dihydro-3H-2-benzazepine N-oxides
Keywords: PD; Parkinson's disease; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; 6-OHDA; 6-hydroxydopamine; MPTP; N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PBN; α-phenyl-N-tert-butylnitrone; ROS; reactive oxygen species; OH; hydroxyl radical; LP